Timing of Breakthrough Infection Risk After Vaccination Against SARS-CoV-2
David N. Fisman, Nelson Lee, View ORCID ProfileAshleigh R. Tuite
doi: https://doi.org/10.1101/2022.01.04.22268773
David N. Fisman
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
MD MPHNelson Lee
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
MD, MBBSAshleigh R. Tuite
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
PhD MPHArticle usage
Posted January 05, 2022.
Timing of Breakthrough Infection Risk After Vaccination Against SARS-CoV-2
David N. Fisman, Nelson Lee, Ashleigh R. Tuite
medRxiv 2022.01.04.22268773; doi: https://doi.org/10.1101/2022.01.04.22268773
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12693)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4554)
- Geriatric Medicine (413)
- Health Economics (724)
- Health Informatics (2903)
- Health Policy (1067)
- Hematology (384)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4321)
- Nursing (233)
- Nutrition (634)
- Oncology (2255)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1194)
- Primary Care Research (493)
- Public and Global Health (6903)
- Radiology and Imaging (1521)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)